CTLA4 and neoplasm: Ly6G depletion rescued antigen-specific T-lymphocyte responses and consistently sensitized T-cell inflamed MOC1 tumors to CTLA-4 mAb-induced rejection, suggesting that gMDSCs are the dominant cell type to contribute to immunosuppression associated with tumor progression within this model.